196 related articles for article (PubMed ID: 27392855)
1. Interaction Between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer's Disease Pathology.
Bangen KJ; Himali JJ; Beiser AS; Nation DA; Libon DJ; Fox CS; Seshadri S; Wolf PA; McKee AC; Au R; Delano-Wood L
J Alzheimers Dis; 2016 Jul; 53(4):1553-62. PubMed ID: 27392855
[TBL] [Abstract][Full Text] [Related]
2. The influence of Apolipoprotein E genotype on regional pathology in Alzheimer's disease.
Sabbagh MN; Malek-Ahmadi M; Dugger BN; Lee K; Sue LI; Serrano G; Walker DG; Davis K; Jacobson SA; Beach TG
BMC Neurol; 2013 May; 13():44. PubMed ID: 23663404
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease.
Kumar NT; Liestøl K; Løberg EM; Reims HM; Mæhlen J
Virchows Arch; 2015 Aug; 467(2):225-35. PubMed ID: 25898889
[TBL] [Abstract][Full Text] [Related]
4. Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status.
Malek-Ahmadi M; Beach T; Obradov A; Sue L; Belden C; Davis K; Walker DG; Lue L; Adem A; Sabbagh MN
Curr Alzheimer Res; 2013 Jul; 10(6):654-9. PubMed ID: 23627755
[TBL] [Abstract][Full Text] [Related]
5. Global and local ancestry modulate APOE association with Alzheimer's neuropathology and cognitive outcomes in an admixed sample.
Naslavsky MS; Suemoto CK; Brito LA; Scliar MO; Ferretti-Rebustini RE; Rodriguez RD; Leite REP; Araujo NM; Borda V; Tarazona-Santos E; Jacob-Filho W; Pasqualucci C; Nitrini R; Yaffe K; Zatz M; Grinberg LT
Mol Psychiatry; 2022 Nov; 27(11):4800-4808. PubMed ID: 36071110
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E4 Mediates the Association Between Midlife Dyslipidemia and Cerebral Amyloid in Aging Women.
Szoeke C; Goodwill AM; Gorelik A; Dennerstein L; Caeyenberghs K; Simpson S; Hill E; Campbell S
J Alzheimers Dis; 2019; 68(1):105-114. PubMed ID: 30689578
[TBL] [Abstract][Full Text] [Related]
7. Plasma Apolipoprotein E3 and Glucose Levels Are Associated in APOE ɛ3/ɛ4 Carriers.
Edlund AK; Chen K; Lee W; Protas H; Su Y; Reiman E; Caselli R; Nielsen HM
J Alzheimers Dis; 2021; 81(1):339-354. PubMed ID: 33814450
[TBL] [Abstract][Full Text] [Related]
8. Effect of apolipoprotein E genotype on Alzheimer's disease neuropathology in a cohort of elderly Norwegians.
Morris CM; Benjamin R; Leake A; McArthur FK; Candy JM; Ince PG; Torvik A; Bjertness E; Edwardson JA
Neurosci Lett; 1995 Dec; 201(1):45-7. PubMed ID: 8830309
[TBL] [Abstract][Full Text] [Related]
9. The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer's disease.
Yassine HN; Rawat V; Mack WJ; Quinn JF; Yurko-Mauro K; Bailey-Hall E; Aisen PS; Chui HC; Schneider LS
Alzheimers Res Ther; 2016 Jun; 8():25. PubMed ID: 27358067
[TBL] [Abstract][Full Text] [Related]
10. Midlife adiposity predicts earlier onset of Alzheimer's dementia, neuropathology and presymptomatic cerebral amyloid accumulation.
Chuang YF; An Y; Bilgel M; Wong DF; Troncoso JC; O'Brien RJ; Breitner JC; Ferruci L; Resnick SM; Thambisetty M
Mol Psychiatry; 2016 Jul; 21(7):910-5. PubMed ID: 26324099
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions.
Ohm TG; Scharnagl H; März W; Bohl J
Acta Neuropathol; 1999 Sep; 98(3):273-80. PubMed ID: 10483785
[TBL] [Abstract][Full Text] [Related]
12. The effect of APOE-epsilon4 on dementia is mediated by Alzheimer neuropathology.
Mortimer JA; Snowdon DA; Markesbery WR
Alzheimer Dis Assoc Disord; 2009; 23(2):152-7. PubMed ID: 19484916
[TBL] [Abstract][Full Text] [Related]
13. APOE ɛ4/ɛ4 Is Associated with Aberrant Motor Behavior Through Both Lewy Body and Cerebral Amyloid Angiopathy Pathology in High Alzheimer's Disease Pathological Load.
Garcia-Segura ME; Fischer CE; Schweizer TA; Munoz DG
J Alzheimers Dis; 2019; 72(4):1077-1087. PubMed ID: 31744003
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.
Chai YL; Yeo HK; Wang J; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CL
J Alzheimers Dis; 2016; 51(4):1111-8. PubMed ID: 26923016
[TBL] [Abstract][Full Text] [Related]
15. Higher prevalence of cerebral white matter hyperintensities in homozygous APOE-ɛ4 allele carriers aged 45-75: Results from the ALFA study.
Rojas S; Brugulat-Serrat A; Bargalló N; Minguillón C; Tucholka A; Falcon C; Carvalho A; Morán S; Esteller M; Gramunt N; Fauria K; Camí J; Molinuevo JL; Gispert JD
J Cereb Blood Flow Metab; 2018 Feb; 38(2):250-261. PubMed ID: 28492093
[TBL] [Abstract][Full Text] [Related]
16. Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease.
Shinohara M; Murray ME; Frank RD; Shinohara M; DeTure M; Yamazaki Y; Tachibana M; Atagi Y; Davis MD; Liu CC; Zhao N; Painter MM; Petersen RC; Fryer JD; Crook JE; Dickson DW; Bu G; Kanekiyo T
Acta Neuropathol; 2016 Aug; 132(2):225-234. PubMed ID: 27179972
[TBL] [Abstract][Full Text] [Related]
17. Nighttime Blood Pressure Interacts with APOE Genotype to Increase the Risk of Incident Dementia of the Alzheimer's Type in Hispanics.
Melgarejo JD; Aguirre-Acevedo DC; Gaona C; Chavez CA; Calmón GE; Silva ER; de Erausquin GA; Gil M; Mena LJ; Terwilliger JD; Arboleda H; Scarmeas N; Lee JH; Maestre GE
J Alzheimers Dis; 2020; 77(2):569-579. PubMed ID: 32675415
[TBL] [Abstract][Full Text] [Related]
18. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
19. Differences in Alzheimer's Disease-Related Pathology Profiles Across Apolipoprotein Groups.
Morrison C; Dadar M; Kamal F; Collins DL;
J Gerontol A Biol Sci Med Sci; 2024 Feb; 79(2):. PubMed ID: 37935216
[TBL] [Abstract][Full Text] [Related]
20. The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease.
Gavett BE; John SE; Gurnani AS; Bussell CA; Saurman JL
J Alzheimers Dis; 2016; 49(2):531-45. PubMed ID: 26444761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
